Contact
Get in touch with TWYCE.
Contact us to discuss our science, pipeline and partnering opportunities in TME-anchored CD28 costimulation for solid tumors.
Start a conversation
Let’s discuss science, development and partnering.
We welcome inquiries from pharma and biotech partners, investors, scientific collaborators, media representatives and other stakeholders interested in the TME-anchored CD28 costimulation platform of TWYCE or its preclinical assets.
Sending opens a pre-filled email in your email program. Nothing is stored on this website.
Direct contact
Reach the TWYCE team.
For direct inquiries, please contact us by email. We will route your message to the appropriate person within the team.
- Email: info@twyce-therapeutics.com
- Address: TWYCE · BiconY GmbH, c/o KKE Translationale Immunologie, Otfried-Müller-Str. 10, 72076 Tübingen, Germany
Partnering
Explore strategic opportunities.
TWYCE is open to flexible, deal-agnostic conversations around its CD28 Signal 2 platform, clinical-stage programs and combination opportunities in solid tumor immunotherapy.